Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positron-Emission Tomography(PET)”

2,480 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,480 results

Not applicableStudy completedNCT01951300
What this trial is testing

68Ga-Citrate PET of Healthy Volunteers

Who this might be right for
Healthy
Turku University Hospital 6
Not applicableLooking for participantsNCT06105411
What this trial is testing

Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions

Who this might be right for
Invasive Fungal Infections
Peter MacCallum Cancer Centre, Australia 10
Not applicableLooking for participantsNCT07335900
What this trial is testing

A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis

Who this might be right for
Severe Aortic Valve Stenosis
RenJi Hospital 25
Early research (Phase 1)Study completedNCT07069725
What this trial is testing

The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.

Who this might be right for
Liver FibrosisHepatic Cirrhosis
AstraZeneca 8
Testing effectiveness (Phase 2)UnknownNCT04141150
What this trial is testing

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics, LLC 130
Not applicableStudy completedNCT00788489
What this trial is testing

A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Breast Cancer
Ontario Clinical Oncology Group (OCOG) 49
Testing effectiveness (Phase 2)Study completedNCT00181168
What this trial is testing

Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Johns Hopkins University 63
Early research (Phase 1)Looking for participantsNCT05629689
What this trial is testing

Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Who this might be right for
Malignant Solid TumorOncology
GE Healthcare 50
Not applicableEnded earlyNCT04874818
What this trial is testing

CD8+ T-cell PET/CT Imaging in COVID-19 Patients

Who this might be right for
Lymphopenia Due to COVID-19T-cellPET Imaging
Radboud University Medical Center 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05467397
What this trial is testing

Feasibility of [11C]Acetate-PET in LAM and TSC

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
Brigham and Women's Hospital 7
Very early researchEnded earlyNCT03757910
What this trial is testing

Brain Imaging in the Diabetes Prevention Program Outcomes Study

Who this might be right for
Alzheimer Disease
José A. Luchsinger 5
Testing effectiveness (Phase 2)Looking for participantsNCT06904313
What this trial is testing

Ultralow Dose PET Imaging for PSMA Expression

Who this might be right for
Healthy VolunteerProstate CA
Akiva Mintz 200
Early research (Phase 1)Study completedNCT01826110
What this trial is testing

PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Johns Hopkins University 21
Not applicableEnded earlyNCT05491902
What this trial is testing

Pilot PET Study of Regional Cerebral Protein Synthesis in Alzheimer's

Who this might be right for
Alzheimer Disease
University of Manchester 10
Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Early research (Phase 1)UnknownNCT00563537
What this trial is testing

Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisBulbar DiseaseSpinal Disease
University Hospital, Tours 30
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Early research (Phase 1)Study completedNCT05666687
What this trial is testing

An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain

Who this might be right for
Major Depressive Disorder
Novartis Pharmaceuticals 10
Early research (Phase 1)Ended earlyNCT07329621
What this trial is testing

A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults

Who this might be right for
Healthy Volunteers
Otsuka Pharmaceutical Development & Commercialization, Inc. 8
Very early researchUnknownNCT04841421
What this trial is testing

Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Sinotau Pharmaceutical Group 30
Next Page